[The use of lamotrigine in female patients]

[The use of lamotrigine in female patients] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[The use of lamotrigine in female patients] Abstract Text:

B Schmitz,L Bergmann,B Schmitz,L Bergmann,

BACKGROUND: Gender aspects are important when assessing the tolerability of antiepileptic drugs (AED). Due to its broad spectrum of action and to the lack of evidence for teratogenicity in monotherapy, lamotrigine (LTG) is an AED of first choice for women with epilepsy with child-bearing potential. METHOD: In an observational study over 6 months including 832 women with epilepsy, we evaluated the efficacy and tolerability of LTG in monotherapy and add-on therapy, with a special focus on parameters of particular importance for women including changes in weight, skin, hair, and patterns of menstruation. RESULTS: Of the treated patients, 94% had seizure reduction of at least 50%. Adverse events occurred in 7.3%; 1% experienced serious adverse events, all of which were reversible. Ninety-six percent continued treatment throughout the observation period, and 83% reported improvement in quality of life by the end of the study. Cognition, functioning at work, and mood improved in 43-54% of patients. In most of them, weight remained stable. Those who were switched from valporate (VPA) or carbamazepine (CPZ) to LTG lost 3.2 kg and 3.1 kg (means), respectively. Many of the women described problems related to menstruation at the beginning of the study: variability in cycle length (31.2%), hypermenorrhea (17.3%), and pains (10%). Skin and hair problems were reported by 18.4% and 17.3%, respectively. There was improvement in all of these aspects at the end of the study, particularly for those women switched from VPA or CBZ to LTG. CONCLUSION: In summary, this observational study confirms the good tolerability of LTG with respect to issues particularly relevant to women. More complete elucidation of the correct LTG dosage, which varies widely according to the accompanying medication, will further improve treatment safety.

[The use of lamotrigine in female patients] Publishing Authors By Initials

B Schmitz,L Bergmann,B Schmitz,L Bergmann,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[The use of lamotrigine in female patients] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Der Nervenarzt

VOLUME: 78

Page Numbers: 912-22

Journal Abbreviation:

ISSN: 0028-2804

DAY: 13

MONTH: Aug

YEAR: 2007

[The use of lamotrigine in female patients] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 400773

[The use of lamotrigine in female patients] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [The use of lamotrigine in female patients] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [The use of lamotrigine in female patients]

AFFILIATION: Neurologische Klinik und Poliklinik, Charité, Campus Virchow-Klinikum, Humboldt-Universität Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. bettina.schmitz@charite.de

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nervenarzt

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The use of lamotrigine in female patients Related Publications

• ARK, the Apaf-1 related killer in Drosophila, requires diverse domains for its apoptotic activity.
• Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
• Autophagy and cell death: no longer at odds.
• Comparison of the effects of bilateral posterior dynamic and rigid fixation devices on the loads in the lumbar spine: a finite element analysis.
• Concerning Carnap's definition of extensional and intentional.
• Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis.
• Effects of Enhanced External Counterpulsation (EECP) on Myocardial Perfusion.
• Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial.
• Fractures of the ankylosed spine.
• Genetic variation of foot-and-mouth disease virus isolates recovered from persistently infected water buffalo (Bubalus bubalis).
• Glycan analysis of recombinant Aspergillus niger endo-polygalacturonase A.
• Graphology for the diagnosis of suicide attempts: a blind proof of principle controlled study.
• Health and clinical management - comparing the clinical outcome of computerized strategies. Findings from the section on health and clinical management.
• Health and clinical management - impact on clinical outcome. Findings from the section on health and clinical management.
• Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution.
• Microbial competition, lack in macronutrients, and acidity as main obstacles to the transfer of basidiomycetous ground fungi into (organically or heavy-metal contaminated) soils.
• Mutations of the CEP290 gene encoding a centrosomal protein cause Meckel-Gruber syndrome.
• Regulation of the Arabidopsis root vascular initial population by LONESOME HIGHWAY.
• Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT).
• The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously.
• The Wnt signalling ligand RSPO4, causing inherited anonychia, is not mutated in a patient with congenital nail hypoplasia/aplasia with underlying skeletal defects.
• The bromination of dimethoxystilbenes.
• Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior.
• Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.
• [Follow-up brain imaging after strokes in internal medicine: frequently requested but rarely used for diagnosis or treatment]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [The use of lamotrigine in female patients]